INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 454m ago
HOUSE PTR54m ago
SEC 13F54m ago
ROBINHOOD CHAIN53m ago
HOUSE PTR/PurchaseVerified data

Josh Gottheimer bought MRK

Joint · Merck & Co., Inc. · Merck & Company, Inc. Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Feb 4, 2026
Disclosed
Mar 16, 2026
Disclosure timeline40 days from execution to publication · legal deadline 45 days
Feb 4 executedMar 16, 2026 disclosed

MRK · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
28/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+4 / 15

    Disclosed 40 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MRK

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    Maria Elvira SalazarRSelf
    MRKMerck & Co., Inc.
    Partial sale
    SELL$1,001 – $15KSep 24, 2026Oct 7, 2026
    traded Sep 24, 2026
    +13dHOUSE PTR

    Evidence

    28
    Maria Elvira SalazarRSelf
    MRKMerck & Co., Inc.
    Purchase
    BUY$15K – $50KAug 19, 2026Sep 9, 2026
    traded Aug 19, 2026
    +21dHOUSE PTR

    Evidence

    28
    Maria Elvira SalazarRSelf
    MRKMerck & Co., Inc.
    Purchase
    BUY$15K – $50KAug 19, 2026Sep 9, 2026
    traded Aug 19, 2026
    +21dHOUSE PTR

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034130

    Timestamps

    Event (reported)
    Feb 4, 2026
    Published
    Mar 16, 2026
    Ingested by INSIDER
    Nov 5, 06:47 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Josh Gottheimer
    Role
    JointAs filed: “JT”
    Transaction
    PurchaseAs filed: “P”
    Asset
    Merck & Company, Inc. Common Stock
    Ticker
    MRK
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Feb 4, 2026
    Notification date (reported)
    Mar 5, 2026
    Days from execution to publication
    40

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Josh Gottheimer reported a purchase of Merck & Company, Inc. Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Joint
    Josh Gottheimerbioguide:G000583
    Issuer
    Merck & Co., Inc.cik:0000310158

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.